Engineered in vitro tumor models for cell-based immunotherapy
- 20 April 2021
- journal article
- review article
- Published by Elsevier in Acta Biomaterialia
- Vol. 132, 345-359
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 182 references indexed in Scilit:
- Cancer cell metabolism: implications for therapeutic targetsExperimental & Molecular Medicine, 2013
- Directed differentiation of human pluripotent stem cells into intestinal tissue in vitroNature, 2010
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticlesNature Medicine, 2010
- Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor EradicationMolecular Therapy, 2010
- Fluorescent microparticles for sensing cell microenvironment oxygen levels within 3D scaffoldsBiomaterials, 2009
- Systemic Spread Is an Early Step in Breast CancerCancer Cell, 2008
- Three-dimensional culture models of normal and malignant breast epithelial cellsNature Methods, 2007
- The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expressionMolecular Oncology, 2007
- Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytesBritish Journal of Cancer, 2007
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002